Unrelated Bone Marrow Transplantation for Acquired Aplastic Anemia

Read full text Summarise with VIRAT
Authors: Andrea Paolo Bacigalupo, Rainer F Storb
Cited by: 0
References: 46

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Unrelated bone marrow transplantation (BMT) is a major therapeutic option for patients with acquired severe aplastic anemia (AA): Improved survival has been achieved, thanks to better donor selection, conditioning regimens, and graft versus host disease prophylaxis, together with improved supportive care, including the diagnosis and treatment of opportunistic infections. We will discuss transplantation platforms, as used in unrelated donor transplants, and we will analyze major advances of the past years, including changes in the conditioning regimen and graft versus host disease (GvHD) prophylaxis. These changes extend the option of a bone marrow transplant for patients who lack an HLA-identical sibling and appear to improve engraftment and reduce graft versus host disease; whether this will be true for all age groups is currently being investigated.

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Hematological disorders and diagnostics Blood disorders and treatments

Publication details

Journal / source
Springer eBooks
Pages
159–168
Publication date
25 March 2026
Language
EN
Document type
Book chapter